A phase I dose-ranging study of bendamustine and rituximab in chronic lymphocytic leukemia patients with comorbidities
2017
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
10
References
4
Citations
NaN
KQI